Updates are available Correction dated 2024-11-15

Article History

Received: 26 July 2024

Accepted: 8 October 2024

First Online: 21 October 2024

Change Date: 10 November 2024

Change Type: Update

Change Details: The original online version of this article was revised: Following the publication of the original article, we were notified that "cofunded by the European Union" needs to be added to the Funding section on page 5 and page 32 (Funding {4}).

Change Date: 15 November 2024

Change Type: Correction

Change Details: A Correction to this paper has been published:

Change Details: https://doi.org/10.1186/s13063-024-08581-0

Declarations

:

: Dr. Balmis General University Hospital’'s research ethics committee (Comité de Investigación con Medicamentos, CEiM) will be considered as the central institutional review board. All participating centers must have permission from their local institutional review boards to participate in WATERLAND.

: Not applicable—no identifying images or other personal or clinical details of participants are presented here or will be presented in reports of the trial results. The participant information materials and informed consent form available from the corresponding author on request.

: This is a researcher-driven study. There is little if any, commercial interest in the results of the WATERLAND trial. No industry involvement will be allowed in this study, and the study committee members and collaborators will not be able to participate in this trial in case of conflicts of interest. A declaration of conflicts of interest will be mandatory to be part of the WATERLAND trial.